Angel investment secured

The Electrospinning Company Announces £650,000 Investment to Fund Sales Growth and Increase Capacity Harwell, UK — 26 January 2017 — The Electrospinning Company, announces that it has secured a £650,000 investment to establish itself as the leading provider of clinical-grade electrospun biomaterials to the medical device industry. Funding has come from a network of UK… Read more »

Future of Healthcare Investor Forum – 26 January 2017 – London stock exchange

Ann Kramer and Drummond Paris will be at the 3rd Annual Future of Healthcare Investor Forum with an exhibition stand. The event, sponsored by J.P. Morgan, Numis, Penningtons Manches, PwC and Consilium Strategic Communications, and held in partnership with the MedCity, BioIndustry Association (BIA) and One Nucleus, will highlight the significant investment opportunities within the UK… Read more »

MeDe Innovation – Bradford, UK – 19th Jan 2017

Dr Brendan Robb will attend the fourth annual MeDe Innovation Conference and would be pleased to discuss the application of electrospun scaffolds to orthopaedic regenerative device challenges. The MeDe Innovation Annual Conference is a unique opportunity to access the latest developments in orthopaedic medical device manufacture. The conference brings together MeDe Innovation’s network of academics,… Read more »

3D tumour environment affects DNA damage

Cancer cells grown in 3D in Mimetix scaffolds or spheroid cultures responded to DNA damage  differently to those grown in conventional 2D culture. In “Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase. Joanne Wayne, Teresa Brooks, Andrew J. Massey. DOI: 10.18632/oncotarget.13119″ Vernalis researchers followed the regulation of… Read more »

Electrospinning Company strengthens the Board

The Electrospinning Company has appointed two new members to its Board of Directors to help develop its strategy and drive its growing business in the regenerative medical device sector. Drummond Paris and Nigel Edwards join Kate Ronayne (representing STFC Innovations), Malcolm Chapman (Angel investor) and Ann Kramer (CEO) as well as observer Mark White (Rainbow Seed… Read more »

TERMIS – 11-14 Dec 2016 – San Diego, USA – Booth 203

Come and meet Ann Kramer and Rob McKean at TERMIS AM at booth 203. The theme for the 2016 meeting is “Tissue Engineering and Regenerative Medicine: Personalized and Precise Science, Engineering, and Translation,” reflecting the amazing strides the industry has made to become one of the fastest growing segments in the medical market.

ELRIG Drug Discovery – 13-14 Oct 2016 – Liverpool, UK

ELRIG Drug Discovery Dr Valerie Legris and Stephen Jones will attend on behalf of the company. Our products will be on display at the AMSBio stand #A3. Visit poster  159 to learn how the Mimetix® aligned scaffolds improve both structural and functional read-outs in cardiomyocytes. Visit poster 99 and hear Matt Vassey from Aurelia Bioscience present “A 3-D micro-scaffold platform:… Read more »

TCES 2016 – London – 4-6 July 2016

Dr Valerie Legris is at TCES 2016 at UCL in London. Contact her on info@electrospinning.co.uk to ask about electrospun scaffolds in tissue engineering. The 16th Annual Meeting of the TCES at UCL will bring together the UK research community in cell and tissue engineering, with exciting national and international speakers. Our themed sessions cover diverse… Read more »

TERMIS EU – Uppsala, Sweden – 28 June-1 July

European Chapter Meeting of the Tissue Engineering and Regenerative Medicine International Society 2016 “Towards Future Regenerative Therapies”. 28 June – 1 July, 2016 Uppsala, Sweden Dr Valerie Legris and Dr Brendan Robb will be present with a trade stand. Dr Brendan Robb is a co-author on a poster that will be presented at the conference:… Read more »